VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
+45.16%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.21B
AUM Growth
+$126M
(+12%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-8.58%
Top 10 Holdings %
Top 10 Hldgs %
77.54%
Holding
46
New
4
Increased
3
Reduced
10
Closed
3
Top Buys
| 1 |
ZBIO
Zenas BioPharma, Inc. Common Stock
ZBIO
|
$20M |
| 2 |
Corvus Pharmaceuticals
CRVS
|
$7.91M |
| 3 |
Terns Pharmaceuticals
TERN
|
$5.94M |
| 4 |
Trevi Therapeutics
TRVI
|
$5.39M |
| 5 |
Tenax Therapeutics
TENX
|
$721K |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
$51.8M |
| 2 |
Dyne Therapeutics
DYN
|
$18.7M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$16.9M |
| 4 |
Tarsus Pharmaceuticals
TARS
|
$15.4M |
| 5 |
Cogent Biosciences
COGT
|
$12.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RGLS
26
DELISTED
Regulus Therapeutics
RGLS
| $7.85M | 0.65% |
5,000,000
| – | – |
|
27
ALX Oncology
ALXO
$60.5M
| $7.34M | 0.61% |
4,034,522
-185,526
| -4% | -$338K |
|
28
Compass Therapeutics
CMPX
$595M
| $6.54M | 0.54% |
3,556,023
| – | – |
|
29
IO Biotech
IOBT
$118M
| $6.48M | 0.54% |
6,173,439
| – | – |
|
30
Adverum Biotechnologies
ADVM
$71.8M
| $5.85M | 0.48% |
833,333
| – | – |
|
|
31
Trevi Therapeutics
TRVI
$904M
| $5.39M | 0.45% |
+1,612,903
| New | +$5.39M |
|
32
Verastem
VSTM
$635M
| $4.6M | 0.38% |
1,538,461
| – | – |
|
33
enGene Holdings
ENGN
$279M
| $4.48M | 0.37% |
678,705
| – | – |
|
34
Corbus Pharmaceuticals
CRBP
$120M
| $3.44M | 0.28% |
166,794
| – | – |
|
35
Bolt Biotherapeutics
BOLT
$9.92M
| $2.28M | 0.19% |
176,065
| – | – |
|
|
ALLK
36
DELISTED
Allakos
ALLK
| $1.93M | 0.16% |
2,956,110
-31,890
| -1% | -$20.8K |
|
37
Unicycive Therapeutics
UNCY
$76.5M
| $1.82M | 0.15% |
447,015
+100,000
| +29% | +$408K |
|
38
Aligos Therapeutics
ALGS
$77M
| $1.23M | 0.1% |
141,879
-2
| -0% | -$17 |
|
39
Codexis
CDXS
$215M
| $1.2M | 0.1% |
388,144
| – | – |
|
|
DBVT
40
DBV Technologies
DBVT
$242M
| $948K | 0.08% |
270,887
| – | – |
|
41
Q32 Bio
QTTB
$20.9M
| $917K | 0.08% |
20,559
| – | – |
|
|
42
Tenax Therapeutics
TENX
$27.9M
| $721K | 0.06% |
+208,333
| New | +$721K |
|
43
Precision BioSciences
DTIL
$57.9M
| $41.9K | ﹤0.01% |
4,675
| – | – |
|
|
44
Tarsus Pharmaceuticals
TARS
$2.4B
| – | – |
-565,550
| Closed | -$15.4M |
|
45
Zai Lab
ZLAB
$3.47B
| – | – |
-531,198
| Closed | -$9.21M |
|
|
WHWK
46
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$86.2M
| – | – |
-509,572
| Closed | -$744K |
|